Gentium's Other Investors

Gentium raised a round of funding on , . Investors include Merlin Nexus.

specializes in potential therapeutic agents, the active ingredients of which are derived from natural sources. They are developing Defibrotide for severe Hepatic Veno-Occlusive Disease (VOD), a potent…

Articles about Gentium's Other Investors: